top of page
img_Closed Eye2.jpeg


We bring innovative, elegant, easy to administer, sustained-release

transdermal drug delivery technology to patients.

Intratus, Inc. is a privately held, clinical-stage life sciences company dedicated to the development of its patented, novel, non-invasive, sustained release, and elegant drug delivery platform technologies.

The Intratus portfolio is focused on the treatment of a multitude of ophthalmic diseases in all segments of the eye. Additionally, the platform technology extends to systemic diseases such as cardiovascular disease, diabetes and allergy & immunology.

The company’s IP portfolio provides the foundation for monetizing its internally discovered R&D assets. Intratus is presently headquartered in San Diego, California with operational capacity in the U.S.A., Europe, Asia and South America.

5330 Carroll Canyon Road,

Suite 220  

San Diego, CA 92121, USA

(855) 473-8327

bottom of page